Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.
www.marketwatch.com
#Bayers #stock #jumping #secondary #stroke #drugs #trial #success
Related Posts

What the Fed’s Rate Call Could Mean for the Stock Market
Michael M. Santiago / Getty Images The Fed is set to make its latest interest-rate call Wednesday afternoon. Wall Street…
Can Sean ‘Diddy’ Combs and his business empire recover financially, now that he’s been found not guilty of some charges?
The hip-hop mogul has already seen his net worth plummet from $900 million to $400 million, according to one estimate.…

Oklo Just Got an Energy Department Greenlight. Should You Buy OKLO Stock Here?
Oklo (OKLO) closed higher on Nov. 12 after achieving a transformative regulatory milestone that outweighed its disappointing earnings for the…

